The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characteristics of disease activity able to identify risk categories and probability to respond to first-line endocrine therapy (ET) in HR+ve/HER2-ve metastatic breast cancer (MBC) patients (pts): Dream or reality? Evaluation of a composite risk score in a subgroup population of the GIM 13-AMBRA study.
 
Giorgio Mustacchi
Honoraria - Celgene
Consulting or Advisory Role - Celgene
Travel, Accommodations, Expenses - Celgene; Roche
 
Marina Elena Cazzaniga
Honoraria - Celgene; Pierre Fabre
Consulting or Advisory Role - Celgene; Pierre Fabre
Speakers' Bureau - Pierre Fabre
 
Monica Giordano
No Relationships to Disclose
 
Ornella Garrone
Honoraria - Celgene; Eisai
Research Funding - Celgene (Inst)
 
Alessandra Beano
No Relationships to Disclose
 
Lucia Del Mastro
Honoraria - AstraZeneca; Ipsen; Roche; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Roche
 
Lorenzo Livi
No Relationships to Disclose
 
Laura Iezzi
No Relationships to Disclose
 
Andrea Michelotti
Honoraria - Amgen; Eisai; Novartis; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Ipsen; Pierre Fabre; Roche; Teva
 
Anna Turletti
No Relationships to Disclose
 
Ferdinando Riccardi
No Relationships to Disclose
 
Michele De Laurentiis
Consulting or Advisory Role - AstraZeneca; Celgene; Eisai; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Celgene; Eisai; Novartis; Pfizer; Roche
 
Paolo Marchetti
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; Molteni Farmaceutici; MSD; Novartis; Roche
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Molteni Farmaceutici (Inst); MSD; Roche
 
Laura Biganzoli
No Relationships to Disclose
 
Filippo Montemurro
Speakers' Bureau - AstraZeneca; Novartis; Roche
 
Emanuela Romagnoli
No Relationships to Disclose
 
Sabino De Placido
Research Funding - AstraZeneca (Inst); Pfizer (Inst)
 
Paolo Pronzato
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Travel, Accommodations, Expenses - Novartis; Roche